Align Technology Inc (ALGN)
304.74
-10.23
(-3.25%)
USD |
NASDAQ |
Apr 15, 16:00
304.78
+0.04
(+0.01%)
After-Hours: 20:00
Align Technology Research and Development Expense (Quarterly): 82.16M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 82.16M |
| September 30, 2023 | 88.74M |
| June 30, 2023 | 88.48M |
| March 31, 2023 | 87.45M |
| December 31, 2022 | 83.52M |
| September 30, 2022 | 76.97M |
| June 30, 2022 | 72.96M |
| March 31, 2022 | 71.81M |
| December 31, 2021 | 72.48M |
| September 30, 2021 | 65.59M |
| June 30, 2021 | 57.72M |
| March 31, 2021 | 54.54M |
| December 31, 2020 | 48.89M |
| September 30, 2020 | 44.53M |
| June 30, 2020 | 40.36M |
| March 31, 2020 | 41.53M |
| December 31, 2019 | 41.33M |
| September 30, 2019 | 39.68M |
| June 30, 2019 | 38.85M |
| March 31, 2019 | 37.50M |
| December 31, 2018 | 35.80M |
| September 30, 2018 | 32.70M |
| June 30, 2018 | 30.80M |
| March 31, 2018 | 29.59M |
| December 31, 2017 | 26.17M |
| Date | Value |
|---|---|
| September 30, 2017 | 24.20M |
| June 30, 2017 | 24.38M |
| March 31, 2017 | 22.80M |
| December 31, 2016 | 21.61M |
| September 30, 2016 | 20.42M |
| June 30, 2016 | 18.61M |
| March 31, 2016 | 15.08M |
| December 31, 2015 | 13.89M |
| September 30, 2015 | 17.78M |
| June 30, 2015 | 15.68M |
| March 31, 2015 | 13.88M |
| December 31, 2014 | 13.28M |
| September 30, 2014 | 12.85M |
| June 30, 2014 | 13.29M |
| March 31, 2014 | 13.38M |
| December 31, 2013 | 10.97M |
| September 30, 2013 | 10.92M |
| June 30, 2013 | 10.92M |
| March 31, 2013 | 11.28M |
| December 31, 2012 | 11.71M |
| September 30, 2012 | 9.952M |
| June 30, 2012 | 10.68M |
| March 31, 2012 | 10.53M |
| December 31, 2011 | 9.568M |
| September 30, 2011 | 8.926M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
38.85M
Minimum
Jun 2019
88.74M
Maximum
Sep 2023
63.03M
Average
65.59M
Median
Sep 2021
Research and Development Expense (Quarterly) Benchmarks
| Stryker Corp | 350.00M |
| Edwards Lifesciences Corp | 270.00M |
| Zimmer Biomet Holdings Inc | 113.30M |
| Boston Scientific Corp | 363.00M |
| Haemonetics Corp | 13.26M |